Skip to main content

LCD L33912: Trigger Point Injections

LCD L33912, Trigger Point Injections, is the Local Coverage Determination that First Coast Service Options, Inc. applies to claims from 1 state plus 2 territories (FL, PR, VI), effective 2026-09-06 and first in force 2015-10-01. The policy text runs 376 words, and its billing and coding article A57114 lists 2 ICD-10-CM codes that support medical necessity for 15 procedure codes. 6 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 2 covered ICD-10-CM codes: the same total as L35010 (Novitas Solutions, Inc., 2 codes, revised 2026-09-06) and 8 fewer codes than L34211 (Noridian Healthcare Solutions, LLC, 10 codes, revised 2025-10-23).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
First Coast Service Options, Inc.
States and territories
3
FL PR VI
Revision effective
2026-09-06
Original effective
2015-10-01
Policy text
376 words
Covered ICD-10 codes (articles)
2

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33912
ContractContractorTypeStates
09102First Coast Service Options, Inc.A and B MACFL
09202First Coast Service Options, Inc.A and B MACPR
09302First Coast Service Options, Inc.A and B MACVI

Billing and coding article A57114: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57114 (Billing and Coding: Trigger Point Injections) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57114: Billing and Coding: Trigger Point Injections (Billing and Coding, effective 2026-09-06)

Covered ICD-10-CM codes
2
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
15
Full article
cms.gov record
First 2 covered ICD-10-CM codes in A57114
ICD-10-CMDescription (FY2027)
M79.12Myalgia of auxiliary muscles, head and neck
M79.18Myalgia, other site

Procedure codes: 20552, 20553, J0585 (Injection, onabotulinumtoxina, 1 unit), J0586 (Injection, abobotulinumtoxina, 5 units), J0587 (Injection, rimabotulinumtoxinb, 100 units), J0588 (Injection, incobotulinumtoxin a, 1 unit), J0589 (Injection, daxibotulinumtoxina-lanm, 1 unit), J0702 (Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg), J1010 (Injection, methylprednisolone acetate, 1 mg), J1100 (Injection, dexamethasone sodium phosphate, 1 mg), J2919 (Injection, methylprednisolone sodium succinate, 5 mg), J3121 (Injection, testosterone enanthate, 1 mg), J3300 (Injection, triamcinolone acetonide (triesence), preservative free, 1 mg), J3301 (Injection, triamcinolone acetonide, not otherwise specified, 10 mg), J7040 (Infusion, normal saline solution, sterile (500 ml = 1 unit)).

Coverage indications, limitations and medical necessity

Covered Indications

Trigger Point Injections (TPIs) will be considered reasonable and necessary to treat myofascial pain caused by a trigger point when the following requirements are met:

• There is a focal area of pain in skeletal muscle, directly associated with a palpable, firm nodule within a taut band of muscle fiber 1 ; AND

• Physical examination identifies a focal hypersensitive bundle or nodule of muscle fiber which is palpable and more firm than normal consistency and surrounding muscle, with or without local twitch response and referred pain 1 ; AND

• Patients must be participating in a multimodal program with contemporaneous documentation supporting consistent, active participation in a prescribed pain management plan. 2

Limitations

The following are considered not reasonable and necessary:

• The use of ultrasound (US) guidance for the performance of TPI. 3

• The use of fluoroscopy or magnetic resonance imaging (MRI) guidance for performance of TPI (see rationale for determination).

• A TPI involves the use of local anesthetics (LA) and does not include the use of corticosteroids, saline, biologicals, prolotherapy, platelet-rich plasma (PRP), botulinum toxin, or any other injectates. 2,3 (see Related National Coverage Documents)

• TPI for treating low back pain, 4,5 fibromyalgia, 6 or any other condition not meeting the diagnostic criteria for myofascial pain syndrome (MPS) in absence of trigger points. 2

• The routine performance of more than three (3) TPI sessions within a rolling 12-month period is not reasonable and necessary. In exceptional, clinically appropriate circumstances, a maximum of four (4) sessions may be justified. For such cases, providers must submit an attestation with the claim confirming that all coverage criteria outlined in this policy are met. Providers are advised to consult the Billing and Coding Article for guidance on attestation and documentation requirements. 13

• Five (5) or more TPI sessions per rolling 12-month period per beneficiary. 7(pp21-29)

Notice: Services performed for any given diagnosis must meet all the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. Compliance with the provisions in this LCD may be monitored and addressed through post-payment data analysis and subsequent medical review audits.

Summary of evidence (opening)

History, Background, and/or General Information

Definitions:

Dry Needling (DN) - A technique that involves the insertion of solid filament needles into the skin and underlying tissue to disrupt pain sensory pathways and relax contracted fibers.

Fibromyalgia – A chronic pain syndrome which presents with tender points, somatic symptoms and widespread musculoskeletal pain associated with the development of peripheral and central sensitization.

The contractor cites 164 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-09-06
MCD version
26
Derived from
L29199

Other related documents: A60437 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the First Coast Service Options, Inc. hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L33912 cover?

Trigger Point Injections (TPIs) will be considered reasonable and necessary to treat myofascial pain caused by a trigger point when the following requirements are met: The full 376-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L33912 apply to?

First Coast Service Options, Inc. applies it to Medicare claims in 1 state plus 2 territories: FL, PR, VI. It binds only that contractor; 6 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33912?

The companion billing and coding article A57114 lists 2 ICD-10-CM codes in 1 group that support medical necessity; the first 2 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L33912?

A denial under LCD L33912 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57114's 2 covered diagnosis codes, then file a redetermination with First Coast Service Options, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.